Augean plc
("Augean" or " Company")
PDMR Dealings
The Company has been notified that on 3 March 2021, Harwood Capital LLP, as investment manager to NASCIT, sold 1,500,000 Ordinary shares of 10p each in the capital of the Company ("Ordinary Shares") at a price of 230.0 pence per Ordinary Share. Following this transaction Harwood Capital LLP, as investment manager to NASCIT holds 25,162,500 Ordinary Shares in the Company, representing 24.91% of the total issued share capital.
Details of the transactions can be found in the Notification of Dealing Forms below.
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
|
Harwood Capital LLP as investment manager to NASCIT | |||
2
| Reason for the notification
| ||||
a)
| Position/status
| Christopher Mills, non-exec director of the issuer and director of North Atlantic Smaller Companies Investment Trust plc NASCIT | |||
b)
| Initial notification /Amendment
| Initial Notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Augean plc | |||
b)
| LEI
| 213800FX9OGD148QCP81
| |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares of £0.10 each | |||
| | ||||
Identification code | GB00B02H2F76
| ||||
| | ||||
b)
| Nature of the transaction
| Share disposal | |||
c)
| Price(s) and volume(s) | | | | |
| | Price(s) | Volume(s) | | |
| | 230.00p | 1,500,000 | | |
| | | | | |
d)
| Aggregated information | | |||
| | ||||
- Aggregated volume | N/A - single transaction | ||||
| | ||||
- Price | | ||||
| | ||||
e)
| Date of the transaction
| 3 March 2021 | |||
f)
| Place of the transaction
| London Stock Exchange |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.